Top 40 Biotechnology VC Funds & Investors in Taiwan (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Darwin Venture Management
VC Fund
|
5 | Taiwan, United States, Japan | Seed, Series A | Software, Manufacturing, Information Technology | $350k–$45M |
|
WI Harper Group
VC Fund
|
4 | United States, Taiwan, China | Series A, Seed, Series B | Software, Health Care, Biotechnology | $1.4M–$41M |
|
TopTaiwan
VC Fund
|
3 | Taiwan, United States, Japan | Seed, Series B, Series A | Biotechnology, Medical, Pharmaceutical | $1M–$49M |
|
TaiAn Technologies
VC Fund
|
3 | Taiwan, United States | Series A, Series B, Seed | Biotechnology, Medical, Therapeutics | $7.6M–$23M |
|
Translink Capital
VC Fund
|
3 | United States, China, South Korea | Series A, Series B, Series C | Software, Artificial Intelligence, Information Technology | $2.6M–$58M |
|
National Development Fund of Taiwan Government
VC Fund
|
3 | Taiwan, United States, China | Seed, Series A, Series B | Software, Information Technology, Health Care | $400k–$30M |
|
NCTU Angel Club
VC Fund
|
2 | Taiwan, United States | Seed, Series A | Medical, Health Care, Biotechnology | $750k–$5M |
|
Maxpro Ventures
VC Fund
|
2 | Taiwan, United States | Venture - Series Unknown, Series A, Series B | Biotechnology, Therapeutics, Medical | $10M–$24M |
|
Fubon Financial Holdings
VC Fund
|
2 | Taiwan, United States, Israel | Series A, Venture - Series Unknown, Series B | Biotechnology, Software, Medical | $5M–$700M |
|
China Development Industrial Bank (CDIB)
VC Fund
|
2 | United States, Taiwan, China | Series B, Series C | Biotechnology, Health Care, Pharmaceutical | $7M–$54M |
|
Taiwania Capital Management Corporation
VC Fund
|
2 | United States, Taiwan, United Kingdom | Series A, Series B, Seed | Software, Artificial Intelligence, Biotechnology | $3M–$64M |
|
AVA Angels
VC Fund
|
2 | Taiwan, United States, Singapore | Seed, Series A, Pre-Seed | Software, E-Commerce, Information Technology | $330k–$10M |
|
Verge HealthTech Fund
VC Fund
|
2 | Estonia, Singapore, United Kingdom | Seed, Pre-Seed, Series A | Health Care, Medical Device, Medical | $500k–$4.7M |
|
Hong TAI Electric Industrial
VC Fund
|
1 | Taiwan | Series A | Medical, Wellness, Therapeutics | |
|
Alzheimer's Drug Discovery Foundation
VC Fund
|
1 | United States, Canada, Spain | Grant, Series A, Series B | Biotechnology, Health Care, Medical | $250k–$85M |
|
TMI Holding Corp.
VC Fund
|
1 | Taiwan, United States | Series D | Life Science, Consumer, Software | |
|
Springtec Investment Inc
VC Fund
|
1 | Taiwan | Pre-Seed | Medical, Health Care, Biotechnology | |
|
Black Marble Capital Management
VC Fund
|
1 | Taiwan, Singapore, United States | Seed, Series C, Venture - Series Unknown | Medical, Biotechnology, Manufacturing | $2.8M–$21M |
|
CBC Group
VC Fund
|
1 | Japan, Ethiopia, United States | Series A, Seed | Manufacturing, Apps, News | $4.3M–$50M |
|
Taya Venture Capital
VC Fund
|
1 | United States, Taiwan | Series A, Seed | Biotechnology, Life Science, Biopharma | $21M–$26M |
|
Pangu Venture Capital
VC Fund
|
1 | China, Taiwan, United States | Series A, Seed, Angel | Biotechnology, Apps, SaaS | |
|
KGI Venture Capital
VC Fund
|
1 | Taiwan, Singapore | Series A, Series D | Medical, Biotechnology, Oncology | |
|
Mosaic Venture Lab
VC Fund
|
1 | Taiwan | Seed | Medical, Health Care, Biotechnology | $1.5M–$2M |
|
Diamond Biofund Inc.
VC Fund
|
1 | United States, Taiwan, Israel | Seed, Venture - Series Unknown, Series B | Health Care, Biotechnology, Medical | |
|
Palm Drive Capital
VC Fund
|
1 | United States, Canada, Colombia | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Financial Services | $500k–$33M |
|
CDIB Capital
VC Fund
|
1 | China, Taiwan, United States | Series B, Series A, Series C | Health Care, Biotechnology, Information Technology | $1.5M–$100M |
|
Lippo Group
VC Fund
|
1 | United States, Singapore, China | Seed, Series A | Internet, E-Commerce, FinTech | $3.3M–$4.8M |
|
DERYUN
VC Fund
|
1 | Taiwan | Seed | Medical, Health Care, Biotechnology | |
|
VENTURE+
VC Fund
|
1 | Taiwan | Series A, Seed, Venture - Series Unknown | SaaS, Software, Rental | |
|
DCI Partners
VC Fund
|
1 | Japan, Taiwan, United States | Series B, Series A | Biotechnology, Health Care, Medical | $6.2M–$105M |
|
Biomark Capital
VC Fund
|
1 | Taiwan, United States | Series A, Series E | Health Care, Biotechnology, Medical | |
|
Taiwan Surface Mounting Technology
VC Fund
|
1 | Taiwan | Seed | Medical, Health Care, Biotechnology | |
|
Integrated Capital
VC Fund
|
1 | India, Taiwan, Croatia | Series A, Seed, Series B | E-Commerce, Food and Beverage, Software | $3.4M–$40M |
|
BE Healthcare Ventures
VC Fund
|
1 | Taiwan, Thailand | Seed, Series A, Series B | Health Care, Artificial Intelligence, Medical | $2.4M–$4.1M |
|
Alibaba Entrepreneurs Fund
VC Fund
|
1 | Hong Kong, Taiwan, United States | Series A, Seed, Series B | Software, E-Commerce, Artificial Intelligence | $1.2M–$150M |
|
Center Ventures
VC Fund
|
1 | China, Taiwan | Series A, Series B, Seed | Biotechnology, Pharmaceutical, Medical | $24M–$102M |
|
Bank SinoPac (Hong Kong)
VC Fund
|
1 | India, Taiwan, Hong Kong | Debt Financing, Series A, Post-IPO Debt | Renewable Energy, Solar, Energy | $2.8M–$201M |
|
Mega International Commercial Bank
VC Fund
|
1 | Taiwan, Chile, Philippines | Series A, Debt Financing, Post-IPO Debt | Software, Artificial Intelligence, Energy | $158M–$500M |
|
Might Electronic
VC Fund
|
1 | Taiwan, Hong Kong, The Netherlands | Series A, Seed | Health Care, Medical, Big Data | $1.2M–$3M |
|
Wisdom Capital
VC Fund
|
1 | Taiwan | Seed | Health Care, Biotechnology, Manufacturing | |
| Access all 108 VC funds in Taiwan Biotechnology startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Darwin Venture Management is a venture capital firm headquartered in Taipei, Taiwan, with offices in Hsinchu and the United States. Since our founding in 2009, we have managed eight funds, investing primarily in Series A/B, late-stage, and secondary funds. In 2022, we also launched an evergreen angel fund to enable more nimble bets onpromising early-stage teams, and especially those coming from Taiwan’s superb academic and research institutions. This exposure across stages and borders, coupled with the strong technical background of our team, is the source of Darwin’s differentiation. We recently launched our 8th fund Darjune.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Seed, Series A
- Geography: Taiwan, United States, Japan
Investor stats
- Total investments: 151
- Round size: Seed $350k–$3.1M; Series A $3M–$45M
- Lead/follow: 16% lead, 84% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- bestat — bestat is a developer of platforms for 3D data creation, management, and utilization using AI and offers digital twins services.
- BitBiome — BitBiome is a biotechnology company focused on analyzing microbial genomes and discovering enzymes and proteins that can be applied across industries such as pharmaceuticals, food production, and sustainable manufacturing. The company uses single-cell microbial sequencing technology to study microbes that are difficult to culture throughconventional laboratory methods, enabling the creation of a large microbial genome database called bit-GEM. Its platform supports enzyme discovery, genome analysis, and bioengineering efforts aimed at developing bio-based alternatives for industrial processes. bitBiome also works with academic institutions and commercial partners on research projects involving areas such as biodegradable materials, biomass conversion, and pharmaceutical ingredient synthesis. The company positions microbes as a resource for advancing the bioeconomy by providing tools and data that support biotechnology research and industrial applications.
- PopChill — PopChill generates an online marketplace for second-hand trade, enabling users to share their fashion styles and sell idle items.
We take a diversified approach, investing in the early stage, across multiple sectors with our deep domain expertise.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: United States, Taiwan, China
Investor stats
- Total investments: 155
- Round size: Seed $1.4M–$5M; Series A $2M–$21M; Series B $6M–$41M
- Lead/follow: 23% lead, 77% follow
- Last fund: May invest from a new fund soon — raised $174M in 2016
Portfolio highlights
- Xsensio — Xsensio develops the unique Lab-on-Skin™ sensing platform to sense in real-time biochemical information at the surface of the skin, providing unprecedented real-time information about our health and wellness, in a simple and non-invasive way.The Xsensio Lab-on-Skin™ sensing chip relies on a unique, highly-miniaturized sensing platform developedat the Nanolab of the Swiss Federal Institute of Technology. By leveraging semiconductor properties, our sensing platform unleashes a whole new set of possibilities in continuous health monitoring.
- AdMaster — AdMaster (AdMaster精硕科技) is focused on domestic advertising, and is a third party provider of solutions for marketing massive data in China. It is also the key domestic independent third party of massive data management platform at present. AdMaster aims at helping advertisers to realize the monitoring and optimization of digital marketing effect aswell as improving the overall marketing ROI by technology-driven massive data perception research. AdMaster has a server cluster which processes more than 200 billion data and iterates more than 100 types of data models every month. The main research and service areas include digital marketing effect monitoring and researche, valuation and management of social media marketing effect, analysis and management of social big data, and more.
- R+W — R+W is a global agency & startup incubator based in Hong Kong, Taipei, New York and Washington DC.
TopTaiwan operates as a venture capital management firm. It seeks to invest in industries such as technology, biotechnology, renewable energy, consumer retail, food and beverages, healthcare, and auto parts. The firm was founded in 1996 and is headquartered in Taipei City, Taiwan.
Show more...Investment focus
- Industry: Biotechnology, Medical, Pharmaceutical
- Stage:Seed, Series B, Series A
- Geography: Taiwan, United States, Japan
Investor stats
- Total investments: 21
- Round size: Seed $1M–$3.1M; Series A $3.7M–$6.3M; Series B $10M–$49M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- PopChill — PopChill generates an online marketplace for second-hand trade, enabling users to share their fashion styles and sell idle items.
- MedicalTek — MedicalTek (MDTK) is located in Taichung, Taiwan. We specialize in developing and manufacturing in MonoStereo 3D endoscopic imaging system that using in MIS surgery.
- GRAID Technology — GRAID Technology is headquartered in Silicon Valley, California with an R&D center in Taipei, Taiwan, and has been formed by a team that has more than 15 years’ experience in the SDS, ASIC and storage industries. Our extraordinary software & hardware solution has redefined every aspect of an SSD RAID card, and makes GRAID SupremeRAID™ themost powerful and flexible NVMe SSD RAID card in the world.
TaiAn Technologies Corporation is a technology advisory company that specializes in commercializing intellectual properties in the life sciences. Our team comprised of numerous biomedical experts that work closely with investment professionals to support up-and-coming life science technologies. Most importantly, we are entrusted by our shareholdersto explore technology platforms in the life sciences arena, to build upon the novel technologies, and to transform them into viable business opportunities supporting existing or creating new entities. Our shareholders comprised of Development Fund of the Executive Yuan of Taiwan as well as numerous conglomerates that are recognized in Taiwan and internationally well known. Leveraging our shareholders/ partners' resources and our strong management team, our multiplex services create synergies with Taiwanese corporations and add significant value to your company.
Show more...Investment focus
- Industry: Biotechnology, Medical, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: Taiwan, United States
Investor stats
- Total investments: 8
- Round size: Series A $7.6M–$23M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Primo Biotechnology — Primo Biotechnology harnesses advanced molecular imagin
- AnBogen Therapeutics — Harness the Power of Science to Cure Cancer.
- Elixiron Immunotherapeutics — Elixiron Immunotherapeutics is a company developing therapeutics for cancer, neurological diseases, and inflammatory disorders.
Translink Capital is a trailblazing Silicon Valley VC with unmatched institutional connections to Asia's economic powerhouses.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Series A, Series B, Series C
- Geography: United States, China, South Korea
Investor stats
- Total investments: 170
- Round size: Series A $2.6M–$24M; Series B $9.9M–$42M; Series C $10M–$58M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Opsys Tech — Automotive LiDAR is at its 3rd revolution, led by Opsys Technologies. Our team developed a new ToF True Solid State Scanning LiDAR technology that enables LiDAR with absolutely no moving parts!
- Luxul Technology — TOGE123 menghadirkan koleksi permainan Habanero dengan tampilan menarik fitur modern dan akses yang cepat sehingga pemain dapat menikmati pengalaman bermain yang seru serta berbagai pilihan permainan populer setiap hari
- Winking Entertainment — Headquartered in Singapore. Winking Studios is one of the largest game art outsourcing and game development studios globally.
The national development fund is the management unit of the non-business cycle budget fund, which is tasked with grouping. It aims to accelerate the industrial innovation value-added, promote economic transformation and national development, and help china's industrial innovation value-added, research and development and self-owned brands. Thefinancing method or assisting the competent authorities of the central government to handle the relevant plans to complete the purposes specified in article 30 of the "industry innovation ordinance".
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A, Series B
- Geography: Taiwan, United States, China
Investor stats
- Total investments: 55
- Round size: Seed $400k–$3.1M; Series A $3.1M–$18M; Series B $2.1M–$30M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- H2U — Health to U is a provider of digital health and wellbeing platform, focusing on holistic health, sports, and diets. The H2U Digital Health platform is a breakthrough creation, a framework that maximizes the power of data. The service delivers insightful reviews based on the platform’s analyses of data collected from connected products and services,elevating the overall value of each component. Users are able to get their hands on their records anytime at will, allowing them to stay aware and on top of their physiological states, with access to personalized health solutions and products.
- Numbers Protocol — Explore Numbers Protocol, a leader in blockchain-driven digital media authenticity aligned with C2PA standards. Join our robust platform to secure and verify digital content through advanced blockchain technology.
- CreatorDB — Data-driven creator campaigns across Asia, plus a real-time creator analytics API covering 30M+ YouTube, Instagram, and TikTok profiles.
NCTU Angel Club is an angel investment group that encourages an aspiring young person to start a business.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: Taiwan, United States
Investor stats
- Total investments: 6
- Round size: Seed $2.4M–$3M; Series A $750k–$5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MoBagel — Founded by Stanford and UC Berkeley innovators, MoBagel’s flagship C-Suites AI Builder is powered by Qualcomm AI inference and empowers over 11,000 brands with Agentic AI for BI reporting, forecasting and workflow automation at scale.
- Iweecare — Founded in Taiwan Taipei 2014, iWEECARE is collaborating with electronics manufacturers and TSMT (Taiwan Surface Mounting Technology) to create the best user friendly product- Temp Pal® All their team members are parents and expecting couples, who have experienced the morning hassle of checking BBT (Basic Body Temperature) chart and sleeplessnights worrying about child fever. That’s why they put their engineering and medical expertise to developing Temp Pal®, a device designed to make temperature monitoring easier and more comfortable.
- Mobagel — In 2015, MoBagel established its headquarter in Silicon Valley, with a mission to empower data teams and enterprises to become AI-driven.
Maxpro Ventures is an investment firm focused on breakthrough biomedical technology companies. We identify and invest in such excellent companies worldwide with our private equity and venture capital expertise.
Show more...Investment focus
- Industry: Biotechnology, Therapeutics, Medical
- Stage:Venture - Series Unknown, Series A, Series B
- Geography: Taiwan, United States
Investor stats
- Total investments: 10
- Round size: Series A $10M–$24M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- StellarCell.Bio — StellarCell.Bio is a regenerative medicine company focused on the research, development, and implementation of cell therapy technologies.
- Arthrosi Therapeutics — Arthrosi Therapeutics is a biotechnology company that focuses on drug discovery and development. The company was founded in 2017 and based in Laguna Hills, California.
- Elixiron Immunotherapeutics — Elixiron Immunotherapeutics is a company developing therapeutics for cancer, neurological diseases, and inflammatory disorders.
Fubon Financial Holdings has built a strong lineup of financial service companies. Its major subsidiaries include Fubon Life, Taipei Fubon Bank, Fubon Bank (Hong Kong), Fubon Bank (China), Fubon Insurance, Fubon Securities, and Fubon Asset Management. Fubon Financial Holdings had total assets of US$283.9 billion as of the end of 2019, rankingsecond among Taiwan’s financial holding companies, and it has been the most profitable company in the industry in terms of earnings per share (EPS) for eleven consecutive years. The company was also named to the Fortune Global 500 for the second consecutive year in 2019.
Show more...Investment focus
- Industry: Biotechnology, Software, Medical
- Stage:Series A, Venture - Series Unknown, Series B
- Geography: Taiwan, United States, Israel
Investor stats
- Total investments: 12
- Round size: Series A $5M–$152M; Venture - Series Unknown $21M–$700M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Wonder — Introducing a new kind of home dining experience. Currently available in areas of New Jersey.
- Humanoid — Humanoid creates advanced humanoid robots that integrate seamlessly into daily life, enhancing human potential. Learn more about our mission and vision.
- Tetanti Agribiotech Inc. — Dr. Young holds a PhD degree in agronomy and soil science awarded by University of Hawaii. He is the pioneer in the field of organic fertilizer and soil microorganisms in Taiwan and was awarded the Academician honor in 2016.TTT® technology is the world’s only destructive and innovative concept that revolutionizes the traditional microbialcomposting process with the use of enzymes to stabilize and mature organic wastes. It raises the maturing efficiency more than 100-fold, and our zero pollution composting technology is able to avoid bad smell and waste water produced during the process.Dr. Young has profound influence on the industry in Taiwan and will lead our business to expand internationally as well as establish our group at the top of circular economy.•Broad microorganism and enzyme database:We possess more than 7,000 bacterial isolates that can provide functional and optimized enzyme formulations for different composting materials. •Professional know-how service:The rapid composting technology is a combination of microbiology, biochemistry, soil science, physics, as well as long term practical experiences. It can provide all-around total solution services for any organic wastes. •No more NIMBY protests:Rapid composting technology is pollution-free and can resolve the protests from the neighborhood.
CDIB pioneered venture capital and investment banking in Taiwan and today it remains the predominant leader in venture capital business in Taiwan with a market share of over 30%. Along with Taiwan's industrial development, CDIB has built up a wealth of experience in high-tech investment while its investment overseas has extended to the US,Japan, Korea and S.E. Asia.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series B, Series C
- Geography: United States, Taiwan, China
Investor stats
- Total investments: 63
- Round size: Series B $20M–$51M; Series C $7M–$54M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- AnBogen Therapeutics — Harness the Power of Science to Cure Cancer.
- Formosa Pharmaceuticals — Formosa Pharmaceuticals is a biopharmaceutical firm that specializes in ophthalmology and oncology.
- Elixiron Immunotherapeutics — Elixiron Immunotherapeutics is a company developing therapeutics for cancer, neurological diseases, and inflammatory disorders.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!NEWS Nurturing Stalwarts of Future Industries Taiwan us [...]
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: United States, Taiwan, United Kingdom
Investor stats
- Total investments: 123
- Round size: Seed $3M–$11M; Series A $3M–$64M; Series B $11M–$55M
- Lead/follow: 49% lead, 51% follow
Portfolio highlights
- Luxonis — Build production-ready computer vision with OAK: AI depth cameras, stereo vision, and on-device inference for robotics, automation, and industrial applications.
- Syncell — Advance your research with microscopy-guided tools for high-res protein discovery & mapping. See how our workflow enhances precision and discovery depth.
- Fractyl Health — Fractyl Health develops innovative medical device solutions for the treatment of chronic diseases. The growing product pipeline leverages our minimally invasive procedural therapy, Revita DMR (duodenal mucosal resurfacing), which is designed to rejuvenate the lining of the duodenum and improve patient health. They envision a world with bettersolutions to chronic diseases through the use of less invasive, device-based therapies that will lessen the burden on patients, physicians, and payers.Fractyl Health aims to bring curative therapies to the large populations of patients with metabolic disease.
AVA Angels is an angel group which focus on connecting angel stage to venture stage of startups. AVA Angels has brought together many outstanding angel investors to find and evaluate together high-quality investment targets, to quickly establish the startup ecosystem and the startup investors network.
Show more...Investment focus
- Industry: Software, E-Commerce, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Taiwan, United States, Singapore
Investor stats
- Total investments: 43
- Round size: Seed $330k–$4M; Pre-Seed $350k–$2.5M; Series A $2.5M–$10M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Zeabur — A platform that help you deploy your service with one click, No matter what programming language you use, what framework you use.
- PopChill — PopChill generates an online marketplace for second-hand trade, enabling users to share their fashion styles and sell idle items.
- CreatorDB — Data-driven creator campaigns across Asia, plus a real-time creator analytics API covering 30M+ YouTube, Instagram, and TikTok profiles.
We make early investments in global healthcare technology companies that address prevention, disease management and health system efficiency that are relevant to emerging AsiaWe believe that innovation can happen anywhere, from the streets of Dhaka to the labs of Oxford, however without the right support network, these solutions might notscale, or find the best world-changing application. This is where we can help.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Pre-Seed, Series A
- Geography: Estonia, Singapore, United Kingdom
Investor stats
- Total investments: 28
- Round size: Seed $500k–$4.7M; Pre-Seed $500k–$1M
- Lead/follow: 54% lead, 46% follow
- Last fund: May invest from a new fund soon — raised $17k in 2021
Portfolio highlights
- Zoundream — The Future of Infant Care
- Understanding Zoe — One calm home that remembers for you and grows with your family. Built in Australia for families raising neurodivergent children. Try free for 7 days.
- Neuraworx Medical Technology — Neuraworx Medical Technology is a neurotechnology company developing first-in-class bioelectronic solutions for brain health.
Hong TAI Electric Industrial manufactures electric cables, telecommunication cables, and copper wires.
Show more...Investment focus
- Industry: Medical, Wellness, Therapeutics
- Stage:Series A
- Geography: Taiwan
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- AnHorn Medicines — AnHorn Medicines is a drug discovery company that develops therapeutic medicines for cancer, neurodegeneration, and aging diseases.
- Elixiron Immunotherapeutics — Elixiron Immunotherapeutics is a company developing therapeutics for cancer, neurological diseases, and inflammatory disorders.
The Alzheimer’s Drug Discovery Foundation (ADDF) is the only public charity solely dedicated to finding effective drugs for Alzheimer’s disease. Our pioneering biomedical venture philanthropy approach allows us to invest in the most promising drug discovery and development programs around the world in both academic institutions andbiopharmaceutical companies. Since our founding in 1998, the ADDF has invested nearly $100 million to support over 500 programs across 18 countries.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Grant, Series A, Series B
- Geography: United States, Canada, Spain
Investor stats
- Total investments: 55
- Round size: Grant $250k–$5.8M; Series A $2.1M–$85M; Series B $6M–$73M
- Lead/follow: 73% lead, 27% follow
Portfolio highlights
- AviadoBio — AviadoBio mission is to transform the lives of people living with neurodegenerative disorders by developing and delivering transformative gene therapies for diseases including frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The Company’s technology is based on pioneering research from King’s College London and the UK DementiaResearch Institute.
- Modulo Bio — Modulo is decoding the neuroimmune system. Applying science and engineering to identify new treatment paths for neurodegenerative diseases.
- Circular Genomics — Circular Genomics is a pioneer in precision medicine, leveraging circular RNA biomarkers and bioinformatics to improve psychiatric and neurological medicine
TMI Holding Corp. is a Taipei-based, institutionalized angel investment firm that funds internet and mobile startups.
Show more...Investment focus
- Industry: Life Science, Consumer, Software
- Stage:Series D
- Geography: Taiwan, United States
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- SmartAnalyst — Putnam is a trusted consulting partner that bridges the highest levels of scientific and strategic excellence for global life science companies.
- R+W — R+W is a global agency & startup incubator based in Hong Kong, Taipei, New York and Washington DC.
Investment
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Pre-Seed
- Geography: Taiwan
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Cancerfree Biotech — CancerFree Biotech's platform E.V.A. (Ex Vivo Avatar) uses a proprietary culture system and AI image recognition to expand circulating tumor cells from just 20 mL of blood into 3D tumor organoids. These organoids drive personalized treatment by facilitating drug sensitivity testing and identifying the most effective drugs for each patient. Bytesting therapies directly on patient-derived cells and conducting proprietary organoid analysis, E.V.A. generates personalized screening reports tailored to each patient's unique tumor profile. E.V.A. also supports pharmaceutical companies by validating drug efficacy on patient-derived cells and identifying the most promising candidates for clinical trials. The organoid screening data offers early insights into drug efficacy, reducing the risk of late-stage trial failure and helping to select the best-in-class therapies. Additionally, as a more physiologically relevant model, E.V.A. eliminates the need for traditional cell line and animal testing, producing more accurate and clinically predictive data.
Black Marble Capital Management
Show more...Investment focus
- Industry: Medical, Biotechnology, Manufacturing
- Stage:Seed, Series C, Venture - Series Unknown
- Geography: Taiwan, Singapore, United States
Investor stats
- Total investments: 10
- Round size: Series C $14M–$21M; Venture - Series Unknown $2.8M–$21M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- AIxMed — Beyond Human Insight | AIxMed, Inc.
- AnHorn Medicines — AnHorn Medicines is a drug discovery company that develops therapeutic medicines for cancer, neurodegeneration, and aging diseases.
- AnnJi Pharmaceutical — AnnJi Pharmaceutical is a clinical-stage drug development company that specializes in developing small molecules that address unmet medical needs in the areas of neurology, dermatology, and inflammatory disorders, including rare diseases such as idiopathic pulmonary fibrosis and Kennedy’s disease, and SBMA (Spinal and bulbar muscular atrophy). Thefocus of the company is on creating global collaborations and business partnerships in the late-stage product development and commercialization of pharmaceutical drugs.
CBC Group imports and exports synthetic resins, chemicals, pharmaceuticals, foods, electronics components, and optical equipments.
Show more...Investment focus
- Industry: Manufacturing, Apps, News
- Stage:Series A, Seed
- Geography: Japan, Ethiopia, United States
Investor stats
- Total investments: 12
- Round size: Series A $4.3M–$50M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Dodai — Dodai manufactures and assembles the electric motorcycles.
- Sotas — Sotas provides services to chemical trading companies and bridges the gap between raw material producers and consumers.
- Regional Fish — Regional Fish provides seed, seedlings, aquaculture methods and fisheries services.
Taya Venture Capital Co., Ltd. is a subsidiary of Daya Wire & Cable Group and has focused on discovering and investing in industries with growth potential. The company owns several professional investment funds, including Taya Ventures , Taya Innovation , Taya Genesis, and other NT dollar funds, as well as Taya Venture, a US dollar fund .
Show more...Investment focus
- Industry: Biotechnology, Life Science, Biopharma
- Stage:Series A, Seed
- Geography: United States, Taiwan
Investor stats
- Total investments: 4
- Round size: Series A $21M–$26M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Syncell — Advance your research with microscopy-guided tools for high-res protein discovery & mapping. See how our workflow enhances precision and discovery depth.
- Apeximmune Therapeutics — Apeximmune Therapeutics is pioneering a new generation of therapeutic antibodies and biologics that harness the power of the immune system to deliver curative treatments for cancer and autoimmune disease.
- Protuoso Biosciences — Protuoso Bio is a pioneering biotechnology company developing Next-Gen MUXBODIES for Complex Diseases. We leverage AI-driven protein engineering and synthetic biology to advance innovative oncology drug research.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Pangu Venture Capital a venture capital firm specializing in the Internet, life sciences, cleantech, artificial intelligence, and culture
Show more...Investment focus
- Industry: Biotechnology, Apps, SaaS
- Stage:Series A, Seed, Angel
- Geography: China, Taiwan, United States
Investor stats
- Total investments: 6
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- AutoBrain — AutoBrain focuses on the research and development of advanced and intelligent automatic driving systems.
- No. 1 workplace — No.1 workplace is a workplace service platform. It helps companies and candidates to achieve job matching through AI technology.
- Elixiron Immunotherapeutics — Elixiron Immunotherapeutics is a company developing therapeutics for cancer, neurological diseases, and inflammatory disorders.
KGI Venture Capital Co. Ltd.( KGI Venture Capital), which commenced operations on November 27, 2012, is a 100%-owned subsidiary of KGI Securities.KGI Venture Capital is a leading venture capital firm. The company provides early state capital to private companies and advisory services to its portfolio companies, which benefit from itsvalue-added networks across the Greater China region. KGI Venture Capital's mission is to assist its portfolio companies in becoming market-leading enterprises.
Show more...Investment focus
- Industry: Medical, Biotechnology, Oncology
- Stage:Series A, Series D
- Geography: Taiwan, Singapore
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- AnBogen Therapeutics — Harness the Power of Science to Cure Cancer.
- ASLAN Pharmaceuticals — ASLAN Pharmaceuticals is a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients
Mosaic Venture Lab is an e-mobility innovation platform to co-build products and solutions with entrepreneurs and corporations, creating the new realities of urban mobility.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed
- Geography: Taiwan
Investor stats
- Total investments: 4
- Round size: Seed $1.5M–$2M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- JMEM TEK — Due to the development of the Internet and the growth of the Internet of Everything, traditional software protection is no longer sufficient, and the global environment has entered the era of hardware protection. After four years of research, the team aimed at the shortcomings of the current one-time programming memory, such as insufficient security and large size, and took advantage of the advantages of easy stacking and low cost of polysilicon, High-K and different component structures, through fuses and reflectors. Fuse programming method to complete more bits and more configurations, increase component security and improve existing products are easy to be reverse engineered and consume too much power, etc., develop a new type of polymorphic memory, and unique One can be applied to the most advanced process GAA FET.
- Taiwan Universe BioMedicine — Taiwan Universe BioMedicine represents an innovative platform for developing VLP vaccines targeting enterovirus and influenza. The Bivalent Enterovirus Vaccine targets two strains of enterovirus, while the Seasonal Influenza-like Virus Particle Vaccine mimics surface proteins of seasonal influenza viruses to bolster immunity.
- Taiwan Bio-Manufacturing Corporation — Being a World-Class CRDMOWe provide end-to-end biomanufacturing incomplex modalities by integrating cuttingedge technology MORE We provide end-to-end biomanufacturing in complex modalities by integrating cutting edge technology MORE Company Proposition To establish TBMC as the pioneer in complex biologics manufacturing. MORE Vision Mission Company Proposition To establish TBMC as the pioneer in complex biologics manufacturing. MORE
Diamond BioFund is a company that provides funds in life science sector, dedicated to biotechnology innovation.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Venture - Series Unknown, Series B
- Geography: United States, Taiwan, Israel
Investor stats
- Total investments: 7
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- StemCyte — Proudly helping families as the industry leader in cord blood banking & research. Reach out to learn more: customerservice@stemcyte.com or call 1.888.885.4088
- Rejuvenate Bio — Rejuvenate Bio is a biotechnology company that develops novel gene therapies for dogs. The company's therapy provides a solution for the mitral valve disease to stop the progression of heart failure in dogs, thus providing pets with extended overall health and maximal lifespan. It was founded in 2017 and is based in San Diego, CA.
- Tetanti Agribiotech Inc. — Dr. Young holds a PhD degree in agronomy and soil science awarded by University of Hawaii. He is the pioneer in the field of organic fertilizer and soil microorganisms in Taiwan and was awarded the Academician honor in 2016.TTT® technology is the world’s only destructive and innovative concept that revolutionizes the traditional microbialcomposting process with the use of enzymes to stabilize and mature organic wastes. It raises the maturing efficiency more than 100-fold, and our zero pollution composting technology is able to avoid bad smell and waste water produced during the process.Dr. Young has profound influence on the industry in Taiwan and will lead our business to expand internationally as well as establish our group at the top of circular economy.•Broad microorganism and enzyme database:We possess more than 7,000 bacterial isolates that can provide functional and optimized enzyme formulations for different composting materials. •Professional know-how service:The rapid composting technology is a combination of microbiology, biochemistry, soil science, physics, as well as long term practical experiences. It can provide all-around total solution services for any organic wastes. •No more NIMBY protests:Rapid composting technology is pollution-free and can resolve the protests from the neighborhood.
Venture capital firm backing generational founders at pre-seed and seed. New York and San Francisco.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Financial Services
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, Colombia
Investor stats
- Total investments: 220
- Round size: Seed $1M–$8M; Pre-Seed $500k–$2.5M; Series A $7M–$33M
- Lead/follow: 7% lead, 93% follow
- Last fund: May invest from a new fund soon — raised $75M in 2020
Portfolio highlights
- Jinba — Helping regulated enterprises build and ship production-level AI agents as fast as startups.
- Beglaubigt.de — https://t.co/BCWk4L679n ist die erste Plattform zur Digitalisierung des Notariats in Europa.
- The News Lens — The News Lens is an independent media for Chinese readers. The company aims to be a platform where a wide range of Chinese readers can engage in informed debates about important news, social, and political issues. The News Lens was established in August 2013.
CCIC CDIB International Corp.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Information Technology
- Stage:Series B, Series A, Series C
- Geography: China, Taiwan, United States
Investor stats
- Total investments: 46
- Round size: Series A $1.5M–$16M; Series B $10M–$100M; Series C $4.3M–$40M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $405M in 2015
Portfolio highlights
- Redcliff — Redcliff is a drone management company that organizes aerial shows and events for private and public organizations.
- QT Medical — QT Medical’s technology empowers the patients to take an active role in managing their heart disease. Heart disease is responsible for 1 out of every 4 deaths in the U.S. and is the number 1 killer world-wide. No longer do patients with heart disease have to make long trips to their cardiologists, hospitals, or emergency rooms to get diagnostic,hospital-grade ECG scans. They can now perform these tests from the comfort of their homes or anywhere with an internet connection, allowing peace of mind, saving time, reducing stress, and improving outcomes.
- Shengya Bio — ShengYa Bio is a biotechnology company that specializes in the research, development, and manufacturing of in vitro diagnostic reagents and equipment.
PT Lippo Karawaci Tbk ("Lippo Karawaci") was founded on a vision to impact lives through the development of well-planned sustainable independent townships within green environments and first class physical and social infrastructure. Over more than a decade, the Company has proven itself to be a highly trusted property developer with amost recognisable brand name. It is the owner of the largest diversified landbank and a leader in pioneering projects in strategic locations throughout Indonesia. Through a merger of 8 property related companies in 2004 the Company has expanded its business portfolio to encompass urban development, large scale integrated developments, retail malls, healthcare, hotels and leisure, as well as a fee-based income portfolio.Lippo Karawaci is now the largest listed property company in Indonesia by market capitalisation, assets and revenue, with a unique and integrated business model. It operates Indonesia’s premier private hospital group, the only one achieving world class standards, and is an undisputed retail property industry leader.
Show more...Investment focus
- Industry: Internet, E-Commerce, FinTech
- Stage:Seed, Series A
- Geography: United States, Singapore, China
Investor stats
- Total investments: 11
- Round size: Seed $3.3M–$4.8M
- Lead/follow: 55% lead, 45% follow
Portfolio highlights
- Fairbanc — Fairbanc is a scalable, AI-powered mobile loan and payments platform for emerging market small-medium enterprises (SMEs) that requires no collateral or credit history.The company's AI-powered platform can read digital footprints such as transaction history with large suppliers, and data on the mobile phone to grant instant digital creditline that SMEs can use to purchase inventories from our selected suppliers. Fairbanc's proven gender-intelligent ecosystem for loans and payments can be used in many vertical markets, eliminating the shortcomings of cash. Retail shop-owners can boost sales up to 20%, eliminate cash shortages, enjoy an easier payments regimen, and develop a credit history; suppliers receive more consistent order cycles, more instant payments upon delivery, and SKU sales expansion.
- MoolahGo — Singapore's MAS-licensed cross-border payment platform. Wholesale FX rates, 40+ currencies, full ASEAN coverage. Trusted by 1,000+ businesses and institutions.
- Prenetics — CircleDNA is an at-home, non-invasive DNA test providing health insights across 500+ reports based on your unique genetic blueprint.
DERYUN is a manufacturing and innovation company that solely focuses on quality control.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed
- Geography: Taiwan
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Anivance AI Corporation — Anivance AI Corporation is a Taiwan-based startup specializing in organ-on-chip platforms integrated with artificial intelligence. Leveraging Taiwan’s strengths in semiconductor and precision manufacturing, we deliver user-friendly, cost-effective organ-on-chip solutions enhanced with Multi-Agent AI, making experimental deployment as simple asplugging in a USB. Our platforms cover lung, liver, heart, kidney, tumor, and rare disease models. With thousands of accumulated datasets from collaborations with seven hospitals and global pharmaceutical companies, we have supported over 20 experimental projects, expanded business across North America, Japan, South Korea, and Europe, and hold 35+ patents protecting our proprietary technologies.We pioneer a “No Animals, No Delays, Just Human Data” vision.
VENTURE+ is the next generation venture capital bringing founders not only MONEY but also STRATEGIC VALUES. The company invests in early-stage companies and helps them with growth strategy and critical resources. With solid track records and hands-on experiences, VENTURE+ often plays a co-founding partner role providing more doing than talking. Weare thrilled and good at helping startups make an impact on the world.
Show more...Investment focus
- Industry: SaaS, Software, Rental
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: Taiwan
Investor stats
- Total investments: 8
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- NUEIP — NUEIP focuses on creating smart databases, data visualization, and customized charts to enhance business operations efficiency.
- 25sprout — 25sprout is a digital creative consultancy that provides website development, SaaS, business automation, software and app design.
- Yifang Life — Yifang Life offers services related to rental renovations, leasing, and management, including a tenant management rental plan for tenants.
DCI Partners is a venture capital firm specializing in the fields of drug discovery and regenerative medicine.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: Japan, Taiwan, United States
Investor stats
- Total investments: 19
- Round size: Series A $21M–$105M; Series B $6.2M–$33M
- Lead/follow: 26% lead, 74% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Scohia Pharma — Scohia Pharma is a biotech venture that will have both substantial research and development resources and be nimble enough to make decisions quickly, will strive to improve patient quality of life by providing patients and healthcare professionals with new therapeutic medications for renal, metabolic.
- Surv Biopharma — Surv Biopharma develops a drug discovery platform that facilitates research and development of veterinary drugs and pharmaceutical products.
- Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Biomark Capital provides venture funding and assistance to early, mid, and late-stage life science companies. We target companies with novel approaches to diagnostics, therapeutics, medical devices, and digital health that will change the face of healthcare innovation in the future. We share the drive and vision of our portfolio companies tocollaborate with them in accelerating growth and building successful business ventures.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series E
- Geography: Taiwan, United States
Investor stats
- Total investments: 6
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- i2Dx — i2Dx is developing a multimodal, cloud-based diagnostic platform for the assessment of neurological disorders. The platform will provide quantitative digital assessments of a number of biomarkers that are indicative of brain health with the goal of providing a personalized, longitudinal brain record for healthy individuals and patients.
- Eden Biologics — Eden Biologics, formerly known as JHL Biotech ("JHL") , is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners through the provision of contract development and manufacturing services. We are specialists in manufacturing biologics, from cell line development tocommercial manufacturing with both global and regional regulatory affairs expertise.
- WhiteGlove Health — Affordable, high-quality medical care that comes to you 365 days a year. 8 am to 8 pm every day! 1-877-329-8081
Taiwan Surface Mounting Technology assembles printed circuit boards.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed
- Geography: Taiwan
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Iweecare — Founded in Taiwan Taipei 2014, iWEECARE is collaborating with electronics manufacturers and TSMT (Taiwan Surface Mounting Technology) to create the best user friendly product- Temp Pal® All their team members are parents and expecting couples, who have experienced the morning hassle of checking BBT (Basic Body Temperature) chart and sleeplessnights worrying about child fever. That’s why they put their engineering and medical expertise to developing Temp Pal®, a device designed to make temperature monitoring easier and more comfortable.
Integrated Capital is a multi strategy investment firm investing across private and public equity, private credit and special situations.
Show more...Investment focus
- Industry: E-Commerce, Food and Beverage, Software
- Stage:Series A, Seed, Series B
- Geography: India, Taiwan, Croatia
Investor stats
- Total investments: 13
- Round size: Seed $6.5M–$6.5M; Series A $3.4M–$28M; Series B $12M–$40M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- Entri — India's leading vernacular learning platform for Job Seekers. Learn Coding, Digital Marketing, Commerce, Spoken English and more.
- The Naked Market — The Naked Market is a next-generation consumer products company that is creating a portfolio of food & beverage brands.
- Surglasses — Surglasses specializes in providing cutting-edge augmented reality surgery systems, specifically designed for orthopedics and neurosurgery. These systems offer precise surgical assistance and enhance surgical success rates, improving medical quality and patient safety.
BE Health Ventures is a boutique advisory and investment company, specializing in technologies, financials and healthcare industries.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Medical
- Stage:Seed, Series A, Series B
- Geography: Taiwan, Thailand
Investor stats
- Total investments: 9
- Round size: Seed $2.4M–$4.1M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- Health2Sync — Health2Sync provides patients and care providers with data-driven Digital Therapeutics and personalized healthcare management services including an user-friendly mobile App, cloud-based analytics, and a cloud platform for healthcare professionals.
- AIM — AIM focuses on affordable and easy access to early preventive detection, precision diagnosis and automated prognosis monitoring of prevailing chronic diseases at vast installations of points-of-care.
- H2U — Health to U is a provider of digital health and wellbeing platform, focusing on holistic health, sports, and diets. The H2U Digital Health platform is a breakthrough creation, a framework that maximizes the power of data. The service delivers insightful reviews based on the platform’s analyses of data collected from connected products and services,elevating the overall value of each component. Users are able to get their hands on their records anytime at will, allowing them to stay aware and on top of their physiological states, with access to personalized health solutions and products.
The Entrepreneurs Fund is a not-for-profit initiative launched by Alibaba Group in 2015 to help entrepreneurs and young graduates realize their dreams and vision. Two separate funds have been set up in Hong Kong and Taiwan respectively to support specific programs in each place.
Show more...Investment focus
- Industry: Software, E-Commerce, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: Hong Kong, Taiwan, United States
Investor stats
- Total investments: 75
- Round size: Seed $1.2M–$8M; Series A $2M–$68M; Series B $7M–$150M
- Lead/follow: 45% lead, 55% follow
- Last fund: May invest from a new fund soon — raised $130M in 2015
Portfolio highlights
- Tiiny AI — Tiiny AI offers a ready-to-use open-source ecosystem with one-click installation for models.
- Vpon Holdings — Vpon Holdings is an AI big data analysis and advertising company.
- Ziwu Technology — Ziwu Technology offers the conversion of bio-based waste into sustainable new materials and provides environmentally friendly solutions.
Founded as a pharmaceutical company, they are equipped with practical experience and business expertise in biotechnology. Their familiarity with the industry value chain and ecosystem, along with complete expert network and resource integration capabilities, make us the most professional biotechnology incubator platform in Asia Pacific.
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Medical
- Stage:Series A, Series B, Seed
- Geography: China, Taiwan
Investor stats
- Total investments: 7
- Round size: Series A $24M–$62M; Series B $100M–$102M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Hipot — Hipot is a technological innovation company dedicated to providing hydrogen fuel cell commercial vehicle transportation solutions.
- GenEditBio — GenEditBio is a biotech company that specializes in providing curative gene editing based solutions for genetic diseases.
- Baoji Pharmaceutical — Baoji Pharmaceutical is a biopharma R&D manufacturer, a Sino-foreign joint biopharmaceutical enterprise integrating drug R&D and production.
Bank SinoPac's primary activities include banking, credit cards, trust, insurance, securities, options, venture capital, and overseas investment
Show more...Investment focus
- Industry: Renewable Energy, Solar, Energy
- Stage:Debt Financing, Series A, Post-IPO Debt
- Geography: India, Taiwan, Hong Kong
Investor stats
- Total investments: 4
- Round size: Debt Financing $2.8M–$201M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Lightsource bp — Lightsource bp is a leading global developer, constructor and operator of onshore renewables and energy storage solutions.
- Adani Green Energy — Adani Green Energy Ltd (AGEL) is developing a renewable portfolio of 25 GW by 2025 which includes wind power, solar power, and hybrid power projects.
- Primo Biotechnology — Primo Biotechnology harnesses advanced molecular imagin
Mega International Commercial Bank is a result of the merger of International Commercial Bank of China and Chiao Tung Bank.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Energy
- Stage:Series A, Debt Financing, Post-IPO Debt
- Geography: Taiwan, Chile, Philippines
Investor stats
- Total investments: 7
- Round size: Post-IPO Debt $338M–$356M; Debt Financing $158M–$500M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Gogoro — Gogoro is an electric scooter maker. With a mission to deliver consumer innovations that will improve how the world’s most populated cities distribute and utilize energy, the company is enabling the transformation of megacities into smart cities. Gogoro is working toward a better future by putting power in the hands of everyone – to move us allforward, faster.Founded in 2011, Gogoro is based in Taipei, Taiwan.
- Sierra Gorda SCM — Sierra Gorda SCM is a low-grade mining company that focuses on producing copper and molybdenum concentrates.
- Taiwan AI Cloud Corporation — Taiwan AI Cloud, jointly established by ASUS and the Taiwanese government, has built several TOP500 supercomputers, becoming a leading force in promoting sovereign AI. Like Taiwan's globally renowned semiconductor foundry industry, Taiwan AI Cloud focuses on full-stack AI manufacturing.
Matt Electronics provides one-stop services from product development, design verification, small-scale trial production, mass production to international logistics.
Show more...Investment focus
- Industry: Health Care, Medical, Big Data
- Stage:Series A, Seed
- Geography: Taiwan, Hong Kong, The Netherlands
Investor stats
- Total investments: 4
- Round size: Series A $1.2M–$3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- uHoo — uHoo monitors and manages your indoor environment to help you create healthier, safer and more comfortable homes and workplaces.
- Cubo Ai — Founded by a group of innovators who are also parents, Yunyun technology’s mission is to bring joy and peace of mind to parents everywhere through smart technology and proactive warning systems. In addition to the team’s over 15 years of experience in AI, software, and hardware technology, Yunyun also partnered with renown Taiwan pediatrician,Dr. Sheng-Hsiung Yeh, to develop the world’s first smart AI baby monitor - Cubo! We created Cubo with the belief that we should do all that we can to help protect babies all over the world - we are looking for a partner to help us fulfill this mission! With a user-centric culture and lean startup working model, Yunyun technology has achieved success in Taiwan with over 3000 happy Cubo parents since our launch in May 2018. As one of Appworks top 8 best performing startups in 2018, our team is working hard now to recreate this success and bring this Taiwanese brand to the US. Not only will you be working among innovators, entrepreneurs, and passionate marketers at Yunyun but you’ll also be joining in on the ground floor of this exciting start-up adventure! If this sounds interesting to you, please submit your resume through CakeResume or email us at jobs@getcubo.com.
- BRISE Care — BRISE is an air purifier with A.I. technology.
#Best Discount Broker In #INDIA
Show more...Investment focus
- Industry: Health Care, Biotechnology, Manufacturing
- Stage:Seed
- Geography: Taiwan
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Surglasses — Surglasses specializes in providing cutting-edge augmented reality surgery systems, specifically designed for orthopedics and neurosurgery. These systems offer precise surgical assistance and enhance surgical success rates, improving medical quality and patient safety.
Biotechnology VC funding in Taiwan at a glance
Stats across 88 deals from 108 investors.
Access all 108 VC funds in Taiwan Biotechnology startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotechnology VC Funds in Taiwan investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 108 VC funds investing in Taiwan Biotechnology startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!